Health Issues of Immigrant Children of Color, The
By the year 2050, the population of the United States is projected to be approximately half white and half non-white. Yet the knowledge of child development within ethnic minority groups lags markedly behind knowledge of child development for white Americans, and it is increasingly clear that the rich diversity within minority groups is masked by studies focusing on between-group comparisons. Children of Color: Research, Health, and Public Policy Issues, a collection of original essays, brings together researchers from the fields of education, family and child ecology, nursing, psychology, sociology, pediatrics, anthropology, and social work to explore the rich cultural, familial, and individual diversity of all ethnic minority groups. The essays were generated by round table discussions sponsored by the Society for Research in Child Development and the Irving Harris Foundation, and they cover a broad range of topics including immigration policy, social policy, health status of immigrant infants, children and families, and educational policies related to minority children.
Postoperative Complications in Parkinson's Disease
Two Separate Tracks? A National Multivariate Analysis of Differences between Public and Private Substance Abuse Treatment Programs
Cost-Effectiveness of Three Methods to Enhance the Sensitivity of Papanicolaou Testing
Also a 1998 research report: Medical Advisory Panel, TEC Program, Blue Cross Blue Shield Association
Evaluation of Beta-Blockers, Calcium Antagonists, Nitrates, and Alternative Therapies for Stable Angina
Stable angina is a major health problem that affects over 7 million adult men and women in the United States, with an estimated 350,000 cases annually. Symptomatic therapy is targeted at either reducing oxygen demand by decreasing the work of the heart or increasing oxygen supply by dilating coronary arteries. Acute treatment of an angina episode consists of rest and often sublingual nitroglycerin. Chronic treatment to prevent symptoms has consisted of one or a combination of beta-blockers, calcium antagonists, and long-acting nitrates.
The choice of a first-line anti-anginal drug has been controversial because all three classes have been shown to be effective in relieving symptoms. There are few long-term trials comparing these drugs in controlled studies, and it is unclear whether any of the drug classes decrease mortality or myocardial infarction in patients with stable angina.
To address these important issues, the University of California, San Francisco-Stanford, Evidence-based Practice Center (EPC) conducted a thorough, systematic review and synthesis of the literature on treatment of stable angina and developed an evidence report on the topic. The topic was nominated by the American College of Cardiology, the American Heart Association, and the American College of Physicians. The EPC worked with the nominators' guideline committee to prioritize two topics for this project:
The relative efficacy and safety of beta-blockers, calcium antagonists, and long-acting nitrates in patients who have stable angina.
The efficacy of alternative therapies in patients who have stable angina.
Quality of Life before and after Radio-Frequency Catheter Ablation of Atrioventricular Nodal Re-Entrant Tachycardia
Association of Managed Care Market Share and Health Expenditures for Fee-for-Service Medicare Patients
Systematic Reviews and Evidence-Based Critical Care Medicine: A Step in the Right Direction
Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures
Statement of the American College of Cardiology